$114.035
+3.033 (+2.66%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
ABVX 相似图表分析预测
Alphio's ABVX stock price prediction model matches the current Abivax SA tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $113.58 (-0.40%). The 1-week path is $99.80 (-12.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Abivax SA 股票吗?
Abivax SA is a good buy right now due to its recent funding of $920 million, which supports the U.S. launch of its drug obefazimod, and the positive analyst ratings with targets up to $180. The current RSI of 27.033 indicates the stock is oversold, suggesting a potential rebound. However, the main risk is the negative forward P/E ratio of 0, indicating uncertainty in future earnings performance.
ABVX 股价于 Thursday 收于 $114.04,此前上涨 +2.66%
Abivax SA (ABVX) last closed at $114.035, gaining +2.66%. These facts feed the 1-day and 1-week ABVX price prediction above.
预测驱动因素
Abivax SA(ABVX)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 ABVX 最接近的股票,按相似度排序。
ABVX 季节性分析
Historically the probability of a positive September return for ABVX is 93.18%. September offers the highest probability of a positive month at 93.18%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。